Emcure Pharmaceuticals and its subsidiary Gennova have resolved all legal disputes with US-based HDT Bio Corp. The parties have entered int...

As Covid-19 cases saw an uptick in other countries, the government in November approved Bharat Biotech's intranasal vaccine iNCOVACC for he...

This comes even as the government's advisory group on Covid-19 is awaiting data from the National Institute of Virology (NIV), Pune before ...

While almost 1 billion people have been fully vaccinated in China, the country is still lacking an mRNA shot, with most of the population i...

The research, published in The Lancet, found that antibody levels among Hong Kong health workers who have been fully vaccinated with BioNTe...

The biotech company said the Singapore production facility will have an estimated annual capacity of several hundred million doses of mRNA-...

On Friday, senior executives from companies such as Moderna, GSK and Bharat Biotech addressed various issues on Covid vaccines, including e...

Countries in Europe and Asia, as well as South Africa, are limiting or halting use of AstraZeneca's shot over safety concerns. Rollout of J...

The DBT said it has approved additional funding towards clinical studies of India's first of its kind' mRNA-based COVID-19 vaccine, HGCO19,...

The EU official, who asked not to be named because the matter is confidential, said the EU executive had already decided to approach Pfizer...

The agreement brings the total number of Moderna doses bought by the US to 200 million, enough to immunize 100 million people with the two-...

The recommendations of the Subject Expert Committee (SEC) on COVID-19, which deliberated upon the proposal submitted by the firm for grant ...

It will seek emergency use authorization from the U.S. Food and Drug Administration and conditional approval from the European Union on Mon...

"The idea that we have a 94.5 percent effective vaccine is stunningly impressive. It is really a spectacular result that I don't think anyb...

The trial results are likely to come in by March 2021, Sanjay Singh, CEO of Pune-based Gennova, told ET. There is a possibility that India ...

Britain's GSK said on Monday it would invest 130 million pounds ($163 million) in German biotech firm CureVac for a 10% stake to work toget...

Wipro founder Azim Premji is an investor in Moderna, the firm that has emerged a frontrunner for Covid vaccine.